Analysed VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) News Sources
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
22-06-2026
yahoo.com
Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital
06-08-2026
yahoo.com
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
27-08-2026
yahoo.com
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08-09-2026
yahoo.com
What is the current price of VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ)?
The current price of VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) is $4.6.
VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) since the previous trading day is $-0.18.
VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) since the previous trading day is -3.7657%.
What is the most recent average sentiment score for VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ)?
The most recent average sentiment score for VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ)?
The most recent sentiment for VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ) is .
SEC-8K** Filing Available For VERRICA PHARMACEUTICALS INC (VRCA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.